Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Metabolism and muscle recovery after an ICU stay

Official title: Characterisation of the Inflammatory, Metabolic, and Mitochondrial Profiles in the Context of Post-Intensive Care Muscle Dysfunction

Run by University of Liege · NCT07329530 · Data updated 2026-11-12

We will test whether blood and muscle metabolic and inflammatory markers can help predict how well adults recover muscle strength over three months after an ICU stay or major abdominal surgery.

More Critical Illness trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity of Liege
Academic / other
Locations1 site (Liège)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 31, 2028
Study endsApril 1, 2029
Registry record updatedJanuary 12, 2026
Trial IDNCT07329530 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who survived a critical illness with an anticipated ICU stay of at least seven days or adults undergoing elective major abdominal surgery who can provide informed consent are ideal candidates.

Probably not a fit

Patients with active malignancy, known muscle or inherited metabolic disorders, pregnancy, inability to consent, or contraindications to muscle biopsy, bioelectrical impedance, or indirect calorimetry are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center study recruits adults who survived a critical illness with an anticipated ICU stay of seven days or more and elective major abdominal surgery patients as a comparison group. Investigators will collect blood samples for inflammation markers, nucleosomes, erythrocyte membrane fatty acids, and myokines, and measure resting energy expenditure. Muscle performance will be measured at discharge and followed over three months, with muscle biopsies, bioelectrical impedance, and indirect calorimetry used when feasible. The goal is to link metabolic and neuroendocrine profiles to trajectories of muscle function after ICU discharge.

Why it matters

Potential benefit: If successful, the results could help identify patients at high risk for prolonged muscle weakness so they can receive earlier or more targeted rehabilitation.

How similar studies have gone: Prior studies have shown persistent inflammation and associations with ICU-acquired muscle weakness, but comprehensive metabolic and myokine profiling to predict individual recovery trajectories is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

* Critical illness:
* anticipated ICU stay \>= 7 days
* Major abdominal surgery
* elective surgery

Exclusion Criteria:

* Active malignancy
* Inherited metabolic disorder
* Known muscle disease
* Pregnancy
* Patient refusal
* Patient unable to express informed consent (dementia, confusion)
* Known coagulation disorder (cirrhosis, genetic coagulopathy) or thrombocytopenia \< 100,000/mm³ on the day of biopsy, anemia with hemoglobin \< 9 g/dL on the day of biopsy, or treatment with anticoagulant agents (contraindication to muscle biopsies only)
* Pacemaker or other implanted electronic device (contraindication to bioelectrical impedance analysis only)
* Oxygen therapy (contraindication to indirect calorimetry during spontaneous ventilation)

Where it's running

  • CHU Sart Tilman
    Liège, Belgium
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.